137 related articles for article (PubMed ID: 32999107)
1. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.
Nasrollahi S; Meera NK; Boregowda S
Indian Pediatr; 2020 Sep; 57(9):801-804. PubMed ID: 32999107
[TBL] [Abstract][Full Text] [Related]
2. Harmful excipients in medicines for neonates in Spain.
Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
[TBL] [Abstract][Full Text] [Related]
3. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
Shehab N; Lewis CL; Streetman DD; Donn SM
Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
[TBL] [Abstract][Full Text] [Related]
4. Toxic excipients in medications for neonates in Brazil.
Souza A; Santos D; Fonseca S; Medeiros M; Batista L; Turner M; Coelho H
Eur J Pediatr; 2014 Jul; 173(7):935-45. PubMed ID: 24500397
[TBL] [Abstract][Full Text] [Related]
5. Possible effects of excipients used in the parenteral drugs administered in critically ill adults, children, and neonates.
Sridharan K; Hasan HM; Al Jufairi M; Al Daylami A; Al Ansari E; Qader AM; Pasha SAA
Expert Opin Drug Saf; 2020 Dec; 19(12):1625-1640. PubMed ID: 32767900
[TBL] [Abstract][Full Text] [Related]
6. The Cumulative Daily Tolerance Levels of Potentially Toxic Excipients Ethanol and Propylene Glycol Are Commonly Exceeded in Neonates and Infants.
Valeur KS; Hertel SA; Lundstrøm KE; Holst H
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):523-530. PubMed ID: 29281181
[TBL] [Abstract][Full Text] [Related]
7. Hospitalised neonates in Estonia commonly receive potentially harmful excipients.
Lass J; Naelapää K; Shah U; Käär R; Varendi H; Turner MA; Lutsar I
BMC Pediatr; 2012 Aug; 12():136. PubMed ID: 22931304
[TBL] [Abstract][Full Text] [Related]
8. Potentially harmful excipients in neonatal medicines: a pan-European observational study.
Nellis G; Metsvaht T; Varendi H; Toompere K; Lass J; Mesek I; Nunn AJ; Turner MA; Lutsar I;
Arch Dis Child; 2015 Jul; 100(7):694-9. PubMed ID: 25854872
[TBL] [Abstract][Full Text] [Related]
9. The potentially harmful excipients in prescribed medications in a Neonatal Intensive Care Unit in Kosovo and available safer alternatives.
Koshi B; Grapci AD; Nebija D; Selmani PB; Morina R; Crcarevska MS; Dodov MG; Raichki RS
Turk J Pediatr; 2022; 64(1):49-58. PubMed ID: 35286030
[TBL] [Abstract][Full Text] [Related]
10. Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan.
Saito J; Nadatani N; Setoguchi M; Nakao M; Kimura H; Sameshima M; Kobayashi K; Matsumoto H; Yoshikawa N; Yokoyama T; Takahashi H; Suenaga M; Watanabe R; Imai K; Obara M; Hashimoto M; Yamamoto K; Fujiwara N; Sakata W; Nagai H; Enokihara T; Katayama S; Takahashi Y; Araki M; Iino K; Akiyama N; Katsu H; Fushimi K; Takeda T; Torimoto M; Kishi R; Mitsuya N; Kihara R; Hasegawa Y; Hamada Y; Kimura T; Wada M; Tanzawa A; Yamatani A
J Pharm Health Care Sci; 2021 Jul; 7(1):23. PubMed ID: 34193299
[TBL] [Abstract][Full Text] [Related]
11. Excipient exposure in very low birth weight preterm neonates.
Akinmboni TO; Davis NL; Falck AJ; Bearer CF; Mooney SM
J Perinatol; 2018 Feb; 38(2):169-174. PubMed ID: 29095430
[TBL] [Abstract][Full Text] [Related]
12. Exposure to potentially harmful excipients in medications among neonates at a state hospital in Malaysia.
Wong SW; Chew SP; Abdul Aziz SA; Mohamed Shah N
Drug Dev Ind Pharm; 2024 Mar; ():1-9. PubMed ID: 38459761
[TBL] [Abstract][Full Text] [Related]
13. Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study.
de Souza AS; Dos Santos DB; Rey LC; Medeiros MG; Vieira MG; Coelho HLL
BMC Pediatr; 2016 Jan; 16():13. PubMed ID: 26795213
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas.
Turner MA; Duncan JC; Shah U; Metsvaht T; Varendi H; Nellis G; Lutsar I; Yakkundi S; McElnay JC; Pandya H; Mulla H; Vaconsin P; Storme T; Rieutord A; Nunn AJ
Adv Drug Deliv Rev; 2014 Jun; 73():89-101. PubMed ID: 24239480
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia.
Fister P; Urh S; Karner A; Krzan M; Paro-Panjan D
J Matern Fetal Neonatal Med; 2015; 28(17):2053-61. PubMed ID: 25316561
[TBL] [Abstract][Full Text] [Related]
16. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
[TBL] [Abstract][Full Text] [Related]
17. Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates.
Nellis G; Metsvaht T; Varendi H; Lass J; Duncan J; Nunn AJ; Turner MA; Lutsar I
Paediatr Drugs; 2016 Jun; 18(3):221-30. PubMed ID: 27099961
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
[TBL] [Abstract][Full Text] [Related]
19. A study of the referral patterns of obstetric clinics and the performance of receiving neonatal intensive care units in Taiwan.
Wang ST; Lin CH; Wang JN; Wang CJ; Chen TJ; Yeh TF
Public Health; 1997 May; 111(3):149-52. PubMed ID: 9175457
[TBL] [Abstract][Full Text] [Related]
20. Neonatal Formulations: The Need for a Tailored, Knowledge Driven Approach.
Allegaert K; Cosaert K; van den Anker JN
Curr Pharm Des; 2015; 21(39):5674-9. PubMed ID: 26323412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
